KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Capital Expenditures Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 9.15%
Dec 28, 2025 6.78%
Sep 28, 2025 9.44%
Jun 29, 2025 9.52%
Mar 30, 2025 4.93%
Dec 29, 2024 5.05%
Sep 29, 2024 6.67%
Jun 30, 2024 3.12%
Mar 31, 2024 4.23%
Dec 31, 2023 3.81%
Oct 1, 2023 3.38%
Jul 2, 2023 5.14%
Apr 2, 2023 5.57%
Jan 1, 2023 7.40%
Apr 3, 2022 1.62%
Apr 4, 2021 1.16%
Sep 27, 2020 -1.35%
Jun 28, 2020 -2.85%
Mar 29, 2020 2.85%
Dec 29, 2019 -3.38%
Sep 29, 2019 -0.16%
Jun 30, 2019 0.00%
Mar 31, 2019 0.81%
Dec 30, 2018 -1.60%
Sep 30, 2018 0.25%
Jul 1, 2018 2.56%
Apr 1, 2018 2.34%
Dec 31, 2017 1.48%
Oct 1, 2017 2.98%
Jul 2, 2017 2.87%
Apr 2, 2017 2.21%
Jan 1, 2017 -5.12%
Apr 3, 2016 7.95%
Sep 27, 2015 8.36%
Jun 28, 2015 8.88%
Mar 29, 2015 6.46%
Dec 28, 2014 12.13%
Sep 28, 2014 7.67%
Jun 29, 2014 8.10%
Mar 30, 2014 7.69%